Nina Hallowell

5.9k total citations
124 papers, 4.1k citations indexed

About

Nina Hallowell is a scholar working on Genetics, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Nina Hallowell has authored 124 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Genetics, 49 papers in Public Health, Environmental and Occupational Health and 27 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Nina Hallowell's work include BRCA gene mutations in cancer (58 papers), Ethics in Clinical Research (44 papers) and Genomics and Rare Diseases (14 papers). Nina Hallowell is often cited by papers focused on BRCA gene mutations in cancer (58 papers), Ethics in Clinical Research (44 papers) and Genomics and Rare Diseases (14 papers). Nina Hallowell collaborates with scholars based in United Kingdom, Australia and Sweden. Nina Hallowell's co-authors include Julia Lawton, F Murton, Naureen Ahmad, M. Joanne Douglas, Helen Statham, Rosalind A. Eeles, Lisa Hanna, Claire Foster, Maggie Watson and Anneke Lucassen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.

In The Last Decade

Nina Hallowell

122 papers receiving 3.9k citations

Peers

Nina Hallowell
Kimberly A. Kaphingst United States
Kenneth P. Tercyak United States
Ora L. Strickland United States
Marlene H. Frost United States
Anita Y. Kinney United States
Gail Geller United States
Lidia Schapira United States
Kimberly A. Kaphingst United States
Nina Hallowell
Citations per year, relative to Nina Hallowell Nina Hallowell (= 1×) peers Kimberly A. Kaphingst

Countries citing papers authored by Nina Hallowell

Since Specialization
Citations

This map shows the geographic impact of Nina Hallowell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Hallowell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Hallowell more than expected).

Fields of papers citing papers by Nina Hallowell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Hallowell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Hallowell. The network helps show where Nina Hallowell may publish in the future.

Co-authorship network of co-authors of Nina Hallowell

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Hallowell. A scholar is included among the top collaborators of Nina Hallowell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Hallowell. Nina Hallowell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hallowell, Nina, et al.. (2024). Ethical preparedness in genomic medicine: how NHS clinical scientists navigate ethical issues. Journal of Medical Ethics. 50(8). 517–522. 6 indexed citations
2.
Goriely, Anne, et al.. (2024). Professionals' views on providing personalized recurrence risks for de novo mutations: Implications for genetic counseling. Journal of Genetic Counseling. 34(1). e1910–e1910. 1 indexed citations
4.
Vears, Danya F., Nina Hallowell, Heidi Beate Bentzen, et al.. (2023). A practical checklist for return of results from genomic research in the European context. European Journal of Human Genetics. 31(6). 687–695. 5 indexed citations
5.
Norman, Jane E., Julia Lawton, Sarah J. Stock, et al.. (2021). Feasibility and design of a trial regarding the optimal mode of delivery for preterm birth: the CASSAVA multiple methods study. Health Technology Assessment. 25(61). 1–102. 4 indexed citations
7.
Stirling, D., et al.. (2019). Mainstreaming BRCA1 and BRCA2 testing: an interview study of healthcare professionals' views. European Journal of Human Genetics. 27. 664–665. 1 indexed citations
8.
Hallowell, Nina, Nicholas Jenkins, M. Joanne Douglas, et al.. (2016). A qualitative study of patients’ perceptions of the value of molecular diagnosis for familial hypercholesterolemia (FH). Journal of Community Genetics. 8(1). 45–52. 11 indexed citations
9.
Yi, Huso, Nina Hallowell, Siân Griffiths, & Tak Yeung Leung. (2013). Motivations for Undertaking DNA Sequencing-Based Non-Invasive Prenatal Testing for Fetal Aneuploidy: A Qualitative Study with Early Adopter Patients in Hong Kong. PLoS ONE. 8(11). e81794–e81794. 38 indexed citations
10.
Jenkins, Nicholas, Julia Lawton, M. Joanne Douglas, et al.. (2011). How do index patients participating in genetic screening programmes for familial hypercholesterolemia (FH) interpret their DNA results? A UK-based qualitative interview study. Patient Education and Counseling. 90(3). 372–377. 18 indexed citations
11.
Jenkins, Nicholas, Nina Hallowell, Andrew Farmer, Rury R. Holman, & Julia Lawton. (2010). Participants’ experiences of intensifying insulin therapy during the Treating to Target in Type 2 Diabetes (4‐T) trial: qualitative interview study. Diabetic Medicine. 28(5). 543–548. 24 indexed citations
12.
Hallowell, Nina, James Mackay, Martin Richards, Martin Gore, & Ian Jacobs. (2004). High-Risk Premenopausal Women's Experiences of Undergoing Prophylactic Oophorectomy: A Descriptive Study. Genetic Testing. 8(2). 148–156. 25 indexed citations
13.
Hallowell, Nina, et al.. (2003). Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information - Commentary - Reply. Journal of Medical Ethics. 29(2). 82–83. 2 indexed citations
14.
Hallowell, Nina, Claire Foster, Audrey Ardern‐Jones, et al.. (2002). Genetic Testing for Women Previously Diagnosed with Breast/Ovarian Cancer: Examining the Impact of BRCA1 and BRCA2 Mutation Searching. Genetic Testing. 6(2). 79–87. 69 indexed citations
15.
Hallowell, Nina, Claire Foster, Rosalind A. Eeles, et al.. (2002). The meaning of risk: Women's perceptions of the genetic risk of breast and ovarian cancer following BRCA1/2 mutation searching. European Journal of Human Genetics. 10. 312–312. 1 indexed citations
16.
McAllister, Marion, et al.. (2000). Lay models of inheritance and how they can contribute to coping in families with genetic disease. Journal of Medical Genetics. 37. 1 indexed citations
17.
Hallowell, Nina. (1998). Women's perceptions of prophylactic surgery as a cancer risk management option. Psycho-Oncology. 7. 60–61. 9 indexed citations
19.
Statham, Helen, et al.. (1997). Genetic counselling for breast and ovarian cancer: Why do women attend?. 8. 179–180. 3 indexed citations
20.
Murton, F, et al.. (1997). Family communication following genetic counselling for breast/ovarian cancer. 8. 178–179. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026